Objectives: Mitochondrial oxidative phosphorylation is the key energy source for placental functions and fetal growth. The purpose of this study was to investigate the function of placenta in high risk pregnancies by measuring mitochondrial respiratory chain complex (RCC) activities, and to evaluate the correlation between double test risk ratio and RCC activities. Methods: The placenta samples were collected from 50 pregnant women. The controls consisted of 20 normal uncomplicated pregnancies and the study group (n = 30) consisted of preeclampsia (PE), intrauterin growth restriction (IUGR), advanced maternal age (AMA), twins and preterm deliveries. Complexes I, II–III, IV and citrate synthase (CS) activities were measured by spectrophotometric assays. Results: Complexes I, II–III and IV activities were significantly lower in the study group than the controls (p < 0.05). Complexes I and II–III activities were significantly reduced in placenta of preterm deliveries compared with the controls (p < 0.003). Double test risk ratio was above the cut-off limit (1:300) in 43% of the study group in which decreased complexes I and II–III activities were observed. Conclusions: Impaired placental mitochondria RCC functions can lead to adverse pregnancy outcomes. Pregnant women with high risk in double test should be monitored carefully in terms of PE, IUGR and preterm delivery.
In this study, levels of progranulin (PGRN) and tumor necrosis factor-alpha (TNF-α) were measured to detect the presence of inflammation in lean polycystic ovary (PCOS) patients. 40 lean PCOS patients were assessed by Rotterdam criteria. Forty healthy women with regular menstrual cycles and without biochemical and clinical hyperandrogenism were involved in our study. Blood samples were taken from the patient and control groups for the measurement of progranulin (PGRN), tumor necrosis factor-alpha (TNF-α), lipid parameters, glucose, insulin, and other hormones. Serum PGRN and TNF-α levels were significantly higher in patients with lean PCOS, compared with the control group (p = .037, p = .041). PGRN levels were positively correlated with TNF-α levels in lean PCOS patients. PGRN is known as a ligand for the TNF-α receptor. PGRN level increase in lean PCOS patients may be due to inhibiting the inflammatory effects of TNF-α. To observe the PGRN and TNF-α connection in obesity, further study is needed in obese PCOS patients and obese control groups.
15 February 2022 in Clinical Chemistry and Laboratory Medicine (CCLM)
Objectives: Academics are far from a consensus regarding the effects of pneumatic tube system (PTS) delivery on sample integrity and laboratory test results. As for the reasons for conflicting opinions, each PTS is uniquely designed, sample tubes and patient characteristics differ among studies. This study aims to validate the PTS utilized in Ankara City Hospital for routine chemistry, coagulation, and hematology tests by comparing samples delivered via PTS and porter. Methods: The study comprises 50 healthy volunteers. Blood samples were drawn into three biochemistry, two coagulation, and two hemogram tubes from each participant. Each of the duplicate samples was transferred to the emergency laboratory via Swiss log PTS (aka PTS-immediately) or by a porter. The last of the biochemistry tubes were delivered via the PTS, upon completion of coagulation of the blood (aka PTS-after). The results of the analysis in these groups were compared with multiple statistical analyses. Results: The study did not reveal any correlation between the PTS and serum hemolysis index. There were statistically significant differences in several biochemistry tests. However, none of them reached the clinical significance threshold. Basophil and large unidentified cell (LUC) tests had poor correlations (r=0.47 and r=0.60; respectively) and reached clinical significance threshold (the average percentages of bias, 10.2%, and 15.4%, respectively). The remainder of the hematology and coagulation parameters did not reach clinical significance level either. Conclusions: The modern PTS validated in this study is safe for sample transportation for routine chemistry, coagulation, and hematology tests frequently requested in healthy individuals except for basophil and LUC.
27 March 2022 in Scandinavian Journal of Clinical and Laboratory Investigation
HbA1c measurement is very useful for the follow-up and detection of glycemic disorder, since it is easier and faster test and is independent of the patient's fasting status. In this study, we aimed to perform the comparative evaluation of 3 different methods for HbA1c measurement including capillary electrophoresis, immunoturbidimetric assay and high-performance liquid chromatography-HPLC. This study comprised 134 leftover whole blood samples obtained from the subjects submitted for routine HbA1c testing. All blood samples were collected in EDTA-containing vacutainer tubes. The HbA1c levels were measured simultaneously using three different methods. Bias estimation, method agreement and concordance between the pairwise methods comparisons were evaluated by Bland–Altman plot and Passing–Bablok regression test. HbA1c levels ranged from 3.8% to 13.4% and measured by three different methods to make the comparison. The median values of samples based on immunoturbidimetric method (6.05%, IQR = 1.80) were higher than capillary electrophoresis method (5.90%, IQR = 1.80) and HPLC (5.85%, IQR = 1.80) method. The study group was classified into three subgroups based on the HbA1c levels measured with the HPLC method: Group 1 (n = 57) was composed of subjects with HbA1c levels less than 5.7%, Group 2 (n = 35) had HbA1c levels between 5.7% and 6.4%, Group 3 (n = 42) had HbA1c levels equal and more than 6.5%. To our knowledge, there is no study evaluating the HbA1c measurement on the Atellica® CH 930 Analyzer. We compared the Atellica®CH930 Analyzer with both HPLC and capillary electrophoresis. The Atellica®CH930 Analyzer showed acceptable performance and a strong correlation with both mentioned methods.
Objectives: Polycystic ovarian syndrome (PCOS) is a heterogeneous endocrine condition that influences 15–20 % of women at their fertile age. In this academic work, we aimed to research serum anti-mullerian hormone (AMH) levels using the Vidas® and Atellica® methods and other hormone parameters in PCOS. Methods: This study included 55 controls and 55 PCOS women diagnosed by Rotterdam criteria. AMH levels were measured by Vidas® and the Atellica® devices, and the other parameters were obtained from Ankara Bilkent City Hospital’s Laboratory Information System. Results: The AMH levels utilized by the Vidas® (p<0.001) and the Atellica® (p=0.001) were both more elevated in PCOS women. The Vidas® and the Atellica® methods were well correlated, and the correlation coefficient value was 0.899. The AMH cut-off value was 3.23 μg/L with a sensitivity of 65.5 % and a specificity of 34.5 % by utilizing the Vidas® method and 3.66 μg/L with a sensitivity of 65.4 % and a specificity of 36.4 % by utilizing the Atellica® method. PCOS women’s serum AMH levels were positively correlated with fasting glucose and luteinizing hormone (LH) and negatively correlated with age and progesterone. The PCOS group’s levels of serum estradiol (E2) were notably more elevated and levels of serum prolactin were notably lower than the controls. Conclusions: This study showed that serum AMH levels measured with both the Atellica® and the Vidas® present significant differences between PCOS patients and the controls but still, AMH alone is not diagnostic enough to distinguish PCOS patients from controls.
28 March 2024 in Eskisehir Medical Journal, Eskisehir City Hospital
Giriş: Galektin-3 (Gal-3), birçok biyolojik süreçte rol alan multifonksiyonel bir protein olup en önemli rolü akut ve kronik inflamasyondadır. İnflamasyon, ileri yaşta kognitif gerilemenin ve demansın gelişmesinde önemli bir role sahiptir. Bu çalışmanın amacı galektin-3’ün Alzheimer Hastalığı (AH) patogenezindeki inflamasyonun bir göstergesi olup olmadığının ve bir biyobelirteç olarak kullanılabilirliğinin araştırılmasıdır. Yöntemler: Çalışmaya, 44 Alzheimer hastası ve 44 normal kognitif fonksiyonlu olmak üzere toplam 88 hasta alınmıştır. Bilinen akut veya kronik infeksiyon tanısı olan, kronik inflamatuar hastalığı bulunan hastalar, kanser hastaları ve galektin-3 düzeyini etkileyen romatolojik hastalığı bulunan hastalar dışlanmıştır. Tüm hastalara kapsamlı geriatrik değerlendirme testleri ve nöropsikiyatrik testler uygulanmıştır. Serum galektin-3 düzeyleri ölçülmüştür. Bulgular: A nalizler sonucunda Alzheimer Hastalığı grubunun galektin-3 düzeyi, kontrol grubundan yüksek saptanmıştır. Ancak istatistiksel olarak anlamlı değildir. Global Detoriasyon Skalası (GDS) evrelemesine göre orta-şiddetli AH (GDS evre 6) grubundaki hastaların galektin-3 düzeyleri hafif-orta evredeki (GDS evre 4-5) hastalara göre istatistiksel olarak anlamlı şekilde yüksek saptanmıştır. Galektin-3 düzeyi ile sayı menzili ileri (r = -0,216 P = 0,043) ve geri (r = -0,233 P = 0,029) testi arasında ters yönde, düşük kuvvette, istatistiksel olarak anlamlı bir korelasyon saptanmıştır. Sonuç: Bu çalışma, galektin-3’ün Alzheimer Hastalığı’nın patogenezinde inflamasyon ve oksidatif stres göstergesi olarak önemli bir rol oynadığını göstermektedir. Bu ilişki Alzheimer Hastalığı’nın şiddeti ile ilişkili görünmektedir. Ancak, bu ilişkiyi netleştirmek için daha fazla ve daha kapsamlı prospektif çalışmalara ihtiyaç vardır. Anahtar kelimeler: Alzheimer Hastalığı, Biyobelirteç, Galektin-3, İnflamasyon, Oksidatif stres